Andrew Brandmaier
-
- Breast Cancer Treatment Studies 4
-
- Neurofibromatosis and Schwannoma Cases 5
-
- CAR-T cell therapy research 2
-
- Meningioma and schwannoma management 8
-
- Pituitary Gland Disorders and Treatments 4
-
- Brain Metastases and Treatment 3
-
- PI3K/AKT/mTOR signaling in cancer 3
-
- Aldose Reductase and Taurine 2
- Co-authors
- Shengqi HouWen ShenSilvia C. FormentiHongbo HaoRichard J. AuchusSusan C. PannulloMahboubeh Papari-ZareeiJonathan Knisely
- Cited by
- GeneticsCancer ResearchNeurology
- Journals
- Journal of Clinical Investigation (1 paper)Journal of Molecular Biology (1 paper)Endocrinology (1 paper)
- Partner nations
- United States
In The Last Decade
Andrew Brandmaier
22 papers receiving 375 citations
Peers
Comparison fields: 5 of 69
- Genetics 44
- Cancer Research 62
- Neurology 58
- Oncology 97
- Immunology 60
Countries citing papers authored by Andrew Brandmaier
This map shows the geographic impact of Andrew Brandmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Brandmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Brandmaier more than expected).
Fields of papers citing papers by Andrew Brandmaier
This network shows the impact of papers produced by Andrew Brandmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Brandmaier. The network helps show where Andrew Brandmaier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Brandmaier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 12 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 28 | |
| 9 | 2020 | 44 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 13 | |
| 12 | 2020 | 1 | |
| 13 | 2017 | 81 | |
| 14 | 2017 | 17 | |
| 15 | 2017 | 48 | |
| 16 | 2016 | 1 | |
| 17 | 2010 | 18 | |
| 18 | 2009 | 15 | |
| 19 | 2007 | 25 | |
| 20 | 2005 | 18 |
About Andrew Brandmaier
Andrew Brandmaier is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 24 papers that have together received 378 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (8 papers), Neurofibromatosis and Schwannoma Cases (5 papers), Pituitary Gland Disorders and Treatments (4 papers), Breast Cancer Treatment Studies (4 papers), Brain Metastases and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), CAR-T cell therapy research (2 papers) and Aldose Reductase and Taurine (2 papers). The work is most often cited by research in Genetics (44 citations), Cancer Research (62 citations) and Neurology (58 citations). Andrew Brandmaier has collaborated with scholars based in United States. Frequent co-authors include Shengqi Hou, Wen Shen, Silvia C. Formenti, Hongbo Hao, Richard J. Auchus, Susan C. Pannullo, Mahboubeh Papari-Zareei, Jonathan Knisely, Rohan Ramakrishna and Philip E. Stieg. Their work appears in journals such as Journal of Clinical Investigation, Journal of Molecular Biology and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.